What is ALMU's health score?

Aeluma, Inc. (ALMU) has a TradeApes health score of 33 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ALMU's estimated fair value?

Based on our 5-year discounted cash flow model, Aeluma, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ALMU undervalued or overvalued?

Our model currently rates ALMU as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ALMU... Refresh in a moment for the full analysis.

Aeluma, Inc. (ALMU)

Technology Inconclusive inconclusive weak

$26.84

Updated: 2026-06-04

TradeApes Score

Financial Strength

15 Stressed

Operating Trend

45 Mixed

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

65 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.